Atlas Trials

Impact of Positron Emission Tomography (PET) Imaging in Muscle-invasive Urothelial Carcinoma of the Bladder Staging

Clinical trial NCT02462239 · COMPLETED

Trial details

NCT number
NCT02462239
Sponsor
Ontario Clinical Oncology Group (OCOG)
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Muscle-invasive Bladder Cancer
Start date
2016-05-06
Primary completion
2024-03-31
Enrollment
292

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.